Rosa Catera, PhD Novartis

Rosa holds a Ph.D. in Applied Genetics from The Institute of Molecular Genetics of the National Research Council (University of Pavia, Italy).

She did her Postdoctoral fellowship on Chronic Lymphocytic Leukemia (CLL) at The Feinstein Institute for Medical Research in New York, in the Immunology laboratory of Nicholas Chiorazzi and Kanti Rai.

Rosa joined Novartis in 2012 as Regulatory CMC Associate Manager, in the Oncology Franchise, and moved to the Cell and Gene Therapies Unit within Novartis in 2014.

Rosa is an active member of the Kymriah team that brought this new therapy to the market in a number of countries.